What is TOBI?


TOBI XI is our 11th Annual gathering of orthobiologics thought-leaders from around the globe. Attending TOBI puts you on the cutting edge with the latest research and clinical pearls in orthopedic biologics. Join us to be informed and build relationships with the TOBI community of physicians, researchers and scientists on the forefront of orthopedics.

Watch Trailer

TOBI VIRTUAL 2020 Symposium - June 12-13, 2020, ONLINE

TOBI News

TOBI 2020 Goes Virtual

WATCH VIDEO – COVID Message: TOBI Founder, Dr. Steven Sampson, DO In light of the COVID-19 pandemic, we are adapting our Las Vegas in-person conference into TOBI VIRTUAL 2020, June 12-13, a 100% online experience. TOBI has always done live streaming, and can now feature NEW ways to learn, connect, and grow together, in the comfort and [...]

Regulatory Compliance and More at TOBI XI!

New publication echoes TOBI 2020 theme: Regulatory Compliance, Clinical Data & Protocols. Platelet-Rich Plasma for Knee Osteoarthritis: Internet Marketing and Patient Education—An Appraisal of Content for Websites with the Greatest Search Engine Visibility This publication reviews 181 websites using 3 leading search engines, and discusses the importance of ethical patient information and marketing of orthobiologics. [...]

ON-Foundation Grants for TOBI 2020

Orthoregeneration Network Foundation (ON) and The Orthobiologic Institute (TOBI) proudly announce a collaboration to advance the field together. ON and TOBI offer ten (10) Education Grants to participate in TOBI VIRTUAL 11th Annual TOBI Orthobiologics Symposium, June 12 to 13, 2020.   Important Dates:   March 20, 2020          Online application system [...]

Vertebral Intraosseous Plasma Rich in Growth Factor (PRGF) Infiltrations as a Novel Strategy for the Treatment of Lumbar Pathology

TOBI Faculty, Dr. Kirchner and colleagues, have recently published their case presentation of a novel strategy for the treatment of degenerative low back pain in a recent issue of the Journal of Orthopedic Surgery and Research.  A primary motivation to adopt minimally invasive cell-based therapies in the field of Orthobiologics to treat degenerative conditions of [...]